Medicine / D-0010-2027
U.S. Food and Drug AdministrationD-0010-2027
Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807. NDC: 27241-126-02
Class II Distributed nationwide or U.S.-wide
Status: Ongoing
What was recalled
Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807. NDC: 27241-126-02
Recalling firm
Ajanta Pharma USA Inc
Reason for recall
Failed Dissolution Specifications: below specification
Where it went
Nationwide in the US.
Shown as U.S. Food and Drug Administration published it (shortened where marked …). Recall Shelf does not change recall facts and is not affiliated with the agency.